Literature DB >> 862217

A connective tissue disorder similar to vinyl chloride disease in a patient exposed to perchlorethylene.

G P Sparrow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 862217     DOI: 10.1111/j.1365-2230.1977.tb01532.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  8 in total

1.  What is the contribution of occupational environmental factors to the occurrence of scleroderma in men?

Authors:  A J Silman; S Jones
Journal:  Ann Rheum Dis       Date:  1992-12       Impact factor: 19.103

Review 2.  Epidemiology of scleroderma.

Authors:  A J Silman
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

3.  Unreviewed reports.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-19

4.  Autoimmune potential of perchloroethylene: Role of lipid-derived aldehydes.

Authors:  Gangduo Wang; Jianling Wang; G A Shakeel Ansari; M Firoze Khan
Journal:  Toxicol Appl Pharmacol       Date:  2017-08-14       Impact factor: 4.219

Review 5.  Integrated defense system overlaps as a disease model: with examples for multiple chemical sensitivity.

Authors:  S C Rowat
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

Review 6.  Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis.

Authors:  Carolina Barragán-Martínez; Cesar A Speck-Hernández; Gladis Montoya-Ortiz; Rubén D Mantilla; Juan-Manuel Anaya; Adriana Rojas-Villarraga
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

Review 7.  Epidemiology of organic solvents and connective tissue disease.

Authors:  D H Garabrant; C Dumas
Journal:  Arthritis Res       Date:  1999-12-01

8.  Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes: the POEMS syndrome.

Authors:  R E Solomons; D D Gibbs
Journal:  J R Soc Med       Date:  1982-07       Impact factor: 18.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.